Cleansing Notice
Released
Released
Announcement PDF
ASX Announcement
16 November 2026
Cleansing notice under section 708A(5)(e) of the Corporations Act
This notice is being given by Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (Company)
under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act). The Company
has today issued 85,041 fully paid ordinary shares (Shares).
For the purposes of section 708A(6) of the Corporations Act, the Company advises that:
(a) the Shares were issued without disclosure to investors under Part 6D.2 of the
Corporations Act;
(b) this notice is being given under section 708A(5)(e) of the Corporations Act;
(c) as at the date of this notice the Company, as a disclosing entity under the Corporations
Act, has complied with:
i. the provisions of Chapter 2M of the Corporations Act as they apply to the
Company; and
ii. sections 674 and 674A of the Corporations Act; and
(d) as at the date of this notice, there is no information that is ‘excluded information’ of the
type referred to in sections 708A(7) and 708A(8) of the Corporations Act, which is
required to be disclosed by the Company.
An Appendix 2A relating to the issue of the Shares noted above has been released to ASX.
For further information, please contact:
Maggie Niewidok
Company Secretary
company.secretary@recce.com.au
This announcement has been approved for release by Recce Pharmaceuticals Board.
Share your feedback
Discover